secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvectis Pharma, Inc. (NVCT)
CIK:        0001875558
Form:       8-K
Filed at:   2022-02-04T23:59:59+00:00
Accession:  0001104659-22-011786
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuvectis Pharma prices $16M underwritten offering of 3.2M shares at $5.00; effects 39-for-1 stock split
--------------------------------------------------------------------------------

- Gross proceeds of $16M from sale of 3.2M shares at $5.00; expected close Feb 8, 2022.
- 39-for-1 stock split effective Feb 3, 2022; shares begin trading split-adjusted Feb 4, 2022.
- Authorized common stock increased to 60M shares; authorized preferred stock at 5M shares.
- Underwriting agreement with H.C. Wainwright & Co. as representative of underwriters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1875558/000110465922011786/0001104659-22-011786-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1875558/000110465922011786/tm2134227d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-011786

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer